Cardiff Oncology Inc (NAS:CRDF)
$ 0.83 -0.011 (-1.36%) Market Cap: 64.67 Mil Enterprise Value: 19.27 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 26/100

Cardiff Oncology Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 04:50 PM GMT
Release Date Price: $1.98 (+4.76%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CRDF.OQ - Cardiff Oncology Inc
Cardiff Oncology Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 04:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, I think we will, we'll get started. Welcome back to TD Cowan's 46th annual healthcare conference. I'm Mark Fram from the biotech team here at TD Cowan, and we're really happy to have with us for the next, session on Cardiff Oncology, Manny Mohindre, the interim CEO, who's going to maybe who's going to walk through some slides, kind of level set for people who may not be as familiar with the story, some of the data they've presented, including in the last month or two. In colorectal cancer, and then, we'll use the last few minutes for some Q&A and obviously for people in the room, you're welcome to join in and chime in and get your questions answered, since that's probably more important than my own questions. So
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot